Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
CNS Drugs
|
May 20, 2008
Intermittent subcutaneous apomorphine therapy for 'off' episodes in Parkinson's disease: a 6-month open-label study
Richard M Trosch, Dee Silver, Peter B Bottini
Postgraduate Medicine
|
December 7, 2017
Automated blood pressure monitoring
Peter B Bottini, L Michael Prisant, Albert A Carr
Postgraduate Medicine
|
December 7, 2017
Unstable angina
L Michael Prisant, Jan L Houghton, Peter B Bottini, et al.
Clinical Neuropharmacology
|
November 4, 2008
Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease
Peter A LeWitt, William G Ondo, Brenda Van Lunen, et al.
Postgraduate Medicine
|
December 7, 2017
Hypertensive heart disease
L Michael Prisant, Jan L Houghton, Peter B Bottini, et al.
Parkinsonism & Related Disorders
|
October 24, 2006
Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
Ronald F Pfeiffer, Ludwig Gutmann, Keith L Hull, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
CNS Drugs
|
May 20, 2008
Intermittent subcutaneous apomorphine therapy for 'off' episodes in Parkinson's disease: a 6-month open-label study
Richard M Trosch, Dee Silver, Peter B Bottini
Postgraduate Medicine
|
December 7, 2017
Automated blood pressure monitoring
Peter B Bottini, L Michael Prisant, Albert A Carr
Postgraduate Medicine
|
December 7, 2017
Unstable angina
L Michael Prisant, Jan L Houghton, Peter B Bottini, et al.
Clinical Neuropharmacology
|
November 4, 2008
Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease
Peter A LeWitt, William G Ondo, Brenda Van Lunen, et al.
Postgraduate Medicine
|
December 7, 2017
Hypertensive heart disease
L Michael Prisant, Jan L Houghton, Peter B Bottini, et al.
Parkinsonism & Related Disorders
|
October 24, 2006
Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
Ronald F Pfeiffer, Ludwig Gutmann, Keith L Hull, et al.
Page
of 1